Bahrain approves the Pfizer vaccine for adolescents aged 12-17

The Ministry of Health announced that adolescents aged 12 to 17 years are now eligible to receive two doses of the Pfizer-BioNTech vaccine.

The decision was made after studying all the recommendations issued by the WHO’s Strategic Advisory Group of Experts on Immunization as well as the CDC, to ensure adolescents strengthen their immunity against the virus.

The Taskforce noted that the opening of the vaccination registration for adolescents on will be announced soon. The presence of a guardian is required when taking the vaccine.